Glucose Metabolism in the Fetus and Newborn, and Methods for Its Investigation


Acknowledgments

The authors thank Satish C. Kalhan, MD, as we adapted portions of the text and several figures from his version of this chapter in the prior edition. Dr. Sarah Wernimont was supported by grant T32 DK112751. Dr. Andrew Norris and the previously unpublished data shown in this chapter were supported by grants R01 DK115791, R24 DK96518, and R01 DK097820.

Introduction

Glucose metabolism has been studied extensively in the fetus and newborn, in both animal and human models. The study of glucose metabolism is enabled by the availability of (1) the chronic fetal preparation in large animals, in which fetal blood sampling and physiologic monitoring can be done without causing major changes in the state of the fetus; (2) isotopic tracers, especially stable, nonradioactive ones; (3) molecular biology techniques and transgenic animals; and (4) human molecular genetics. In this chapter, glucose metabolism in the fetus and newborn is discussed. The classic physiology experiments—especially glucose tracer work, which provide core understandings—are reviewed along with recent developments. Throughout the chapter, emphasis is placed on the available data in humans, supplemented when necessary with animal data.

Methods for Studying Glucose Metabolism in the Fetus and Newborn

Isotopic Tracers

Beginning in the 1980s, improvements in the synthesis of metabolites labeled with stable isotopes and sensitive mass-spectrometric methods have allowed investigators to examine glucose metabolism in the human fetus and newborn. In addition, improved synthetic techniques have increased the number of isotopic tracers that can be used simultaneously, allowing investigators to answer more complex questions. By combining novel tracer methods with measurements of energy consumption, the metabolic fate of fuel substrates (e.g., glucose, amino acids, fatty acids) can be quantified along with their contribution to overall fuel economy. To help localize these processes, imaging techniques have been developed to interrogate fetal usage of fuel substrates in a visuospatial and quantitative manner.

Isotopic tracers have proved invaluable in understanding the details of fuel metabolism. They can be used in vivo to quantify rates of metabolic turnover including the appearance and disappearance of a substrate, to quantify the utilization and metabolic fate of a substrate, to determine the contribution of a substrate to another compound, and/or to determine tissue-specific aspects of metabolism. The isotopic labels employed in tracers can be either stable or radioactive, with each having differing merits. The obvious advantage of stable isotopic tracers is that they are nonradioactive. However, another major advantage is that they often can be designed to carry positional information that delineates how specific portions of a molecule are metabolically transformed. Mass spectrometry is used to detect stable isotopic tracers. One disadvantage of stable isotopes is that they are typically less sensitive than radioactive tracers, owing in part to a higher natural abundance, and thus greater amounts of tracer are often required than for radioactive tracers. This point highlights a major advantage of radioactive tracers, in that even very small amounts can be detected. Another advantage of certain radioactive tracers, especially those that emit positrons, is that they can be imaged to determine their location in the body in real time. An example of imaging a glucose uptake tracer during pregnancy in rats is shown in Fig. 36.1 (experimental details are described by Sawatzke and colleagues ). However, a disadvantage of radioactive tracers is that they do not provide molecular positional information as readily compared to stable isotope tracers. Additionally, their radioactivity limits their use in human studies. Isotopic tracer experimentation is not only a complex subject with various pitfalls but also an opportunity for savvy and informative designs as highlighted in recent reviews.

Fig. 36.1, Visuospatial localization of glucose uptake in the pregnant rat using positron emission tomography/computed tomography (PET/CT) . Images show the abdomen of a pregnant rat near term gestation. CT with intravenous contrast was used to help identify abdominal structures. “ P ” identifies one of the several placentae, which contain contrast and have an appearance similar to jellyfish. “ F ” identifies one of the several fetuses, with ribs easily seen. The contrast material does not cross the placenta, so fetal structures are darker (other than fetal bones). “ B ” shows one of the maternal bones. The PET imaging used 18 F-fluorodeoxyglucose (FDG) tracer. FDG is a non-metabolizable glucose analog that cannot be exported from most cells, except those that express glucose-6-phosphatase (mainly the postnatal liver). Hence FDG is considered a glucose uptake tracer and accumulates in glucose-avid tissues. The glucose-avid nature of placenta and fetus is apparent. FDG also accumulates in urine, so the maternal bladder and kidney have been subtracted from the image. The middle panel shows co-registration of the CT and PET images, using a different PET color scale.

Measurements of Energy Expenditure

Measurements of energy expenditure have become integral components of metabolic studies. There are several experimental approaches to measure energy expenditure, and the two most commonly employed techniques are indirect calorimetry and doubly labeled water. Additionally, studies using carbon-labeled tracers can be used to estimate the isotopic enrichment of CO 2 either in the blood or in the expired CO 2 to quantify the oxidation rate of that particular labeled substrate. ,

Indirect Calorimetry

Energy expenditure can be estimated from the rate of oxygen consumption and carbon dioxide production by an infant. In this system, a hood or canopy is placed over the subject’s head, and a pump is used to draw air through the hood. The air exiting from the hood is thoroughly mixed. The concentration of O 2 and CO 2 is measured in the mixed air as is the total flow of air through the system. From this information, energy expenditure can be estimated. This general approach has been used over many years in a large number of studies in adults, children, and newborn infants, , and its limitations have been examined. ,

Doubly Labeled ( 2 H 2 18 O) Water

Doubly labeled water contains the stable isotopes deuterium and 18 O, and can be used to measure energy expenditure by enabling estimation of the rate of CO 2 elimination from the body. Its advantages include that it can be applied to free-living individuals, that CO 2 elimination is measured over hours to days providing an integrated measure of energy consumption, and that the method is relatively simple and noninvasive. It requires administration of a single dose of doubly labeled H 2 O and a few subsequent samples of urine, saliva, or blood to be obtained to measure the changes in isotopic enrichment over several days. The underlying general principle is that the deuterium in doubly labeled water is eliminated as water ( 2 H 2 O), whereas the oxygen ( 18 O) is eliminated with water (H 2 18 O) and with carbon dioxide (CO 18 O), owing to the rapid equilibrium between H 2 O and CO 2 in the body. Thus the difference in turnover rates between the 18 O and 2 H of water represents the CO 2 elimination rate. Use of doubly labeled water to study energy metabolism has been extensively evaluated in humans, both adults and newborns.

Glucose Metabolism in the Fetus

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here